EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

Is blood the new stool? Status of blood tests for CRC screening

Erin L Symonds, Maddison Dix, Molla M Wassie, Norma B Bulamu, Graeme P Young, Jean M Winter

Best Practice & Research Clinical Gastroenterology · 2026

DOI: 10.1016/j.bpg.2025.102049 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2026. Verfasst von Erin L Symonds und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Flinders Medical Centre, Bedford Park, SA 5042, Australia; Flinders Health and Medical Research Institute, Flinders Univ…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Colorectal Neoplasms, Mass Screening, Occult Blood. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council South Australia, National Health and Medical Research Council, Flinders University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) screening has proven to decrease CRC incidence and mortality, with many countries providing faecal immunochemical tests (FIT) in screening programs. Effectiveness, however, is limited in the setting of low participation rates, which has prompted growing research into blood-based screening. While blood testing is anticipated to improve participation due to greater population acceptability, its readiness for widespread implementation remains unclear, and comparative accuracy data against FIT is needed. This article provides a systematic review and meta-analysis on blood-based CRC screening tests that have been directly compared to FIT, and summarises the evidence for broader program considerations, including analytical quality, consumer preferences, participation rates and cost effectiveness. The findings show that blood tests currently lack the sensitivity and cost-effectiveness to replace FIT in screening programs, and that their use should be limited to individuals unable or unwilling to complete FIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorColorectal NeoplasmsMass ScreeningOccult BloodHumansCirculating Tumor DNACost-Benefit AnalysisCost-Effectiveness AnalysisEarly Detection of CancerFecesPredictive Value of TestsSensitivity and Specificity

Stichwörter der Autor:innen

AccuracyBloodCirculating tumour DNAColorectal cancerFaecal immunochemical testScreeningSensitivitySpecificity

Substanzen

Biomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • Gastroenterology Department, Flinders Medical Centre, Bedford Park, SA 5042, Australia; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia. Electronic address: erin.sym…
  • Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.

Förderung

  • Cancer Council South Australia
  • National Health and Medical Research Council
  • Flinders University

Zitieren

APA

Symonds, E. L., Dix, M., Wassie, M. M., Bulamu, N. B., Young, G. P., & Winter, J. M. (2026). Is blood the new stool? Status of blood tests for CRC screening. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.102049

Vancouver

Symonds EL, Dix M, Wassie MM, Bulamu NB, Young GP, Winter JM. Is blood the new stool? Status of blood tests for CRC screening. Best Practice & Research Clinical Gastroenterology. 2026. doi:10.1016/j.bpg.2025.102049

BibTeX
@article{Symonds2026,
  author = {Symonds, Erin L and Dix, Maddison and Wassie, Molla M and Bulamu, Norma B and Young, Graeme P and Winter, Jean M},
  title = {Is blood the new stool? Status of blood tests for CRC screening},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2026},
  doi = {10.1016/j.bpg.2025.102049}
}
Kostenlos starten →